Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
14%
Ph phase_2
1
14%
Ph not_applicable
5
71%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(6)

Detailed Status

Completed6
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (14.3%)
Phase 21 (14.3%)
N/A5 (71.4%)

Trials by Status

completed686%
enrolling_by_invitation114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7